Global Covid-19 Testing 麻豆原创 Research Report 2024

Publication ID:

PB506245337

Publication Date:

June 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.
The global Covid-19 Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Covid-19 Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Covid-19 Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Covid-19 Testing in 麻豆原创 is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Covid-19 Testing include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Testing.
Report Scope
The Covid-19 Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Covid-19 Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
Segment by Application
麻豆原创
Hospital
Clinical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Covid-19 Testing 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rapid Diagnostic Test (RDT)
1.2.3 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.4 Neutralization Assay
1.3 麻豆原创 by Application
1.3.1 Global Covid-19 Testing 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 麻豆原创
1.3.3 Hospital
1.3.4 Clinical
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Testing 麻豆原创 Perspective (2019-2030)
2.2 Covid-19 Testing Growth Trends by Region
2.2.1 Global Covid-19 Testing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Covid-19 Testing Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Covid-19 Testing Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Covid-19 Testing 麻豆原创 Dynamics
2.3.1 Covid-19 Testing Industry Trends
2.3.2 Covid-19 Testing 麻豆原创 Drivers
2.3.3 Covid-19 Testing 麻豆原创 Challenges
2.3.4 Covid-19 Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Testing Players by Revenue
3.1.1 Global Top Covid-19 Testing Players by Revenue (2019-2024)
3.1.2 Global Covid-19 Testing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Covid-19 Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Testing Revenue
3.4 Global Covid-19 Testing 麻豆原创 Concentration Ratio
3.4.1 Global Covid-19 Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Testing Revenue in 2023
3.5 Covid-19 Testing Key Players Head office and Area Served
3.6 Key Players Covid-19 Testing Product Solution and Service
3.7 Date of Enter into Covid-19 Testing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Testing Breakdown Data by Type
4.1 Global Covid-19 Testing Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Covid-19 Testing Forecasted 麻豆原创 Size by Type (2025-2030)
5 Covid-19 Testing Breakdown Data by Application
5.1 Global Covid-19 Testing Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Covid-19 Testing Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Covid-19 Testing 麻豆原创 Size (2019-2030)
6.2 North America Covid-19 Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Covid-19 Testing 麻豆原创 Size by Country (2019-2024)
6.4 North America Covid-19 Testing 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Testing 麻豆原创 Size (2019-2030)
7.2 Europe Covid-19 Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Covid-19 Testing 麻豆原创 Size by Country (2019-2024)
7.4 Europe Covid-19 Testing 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Testing 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Covid-19 Testing 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Covid-19 Testing 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Covid-19 Testing 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Testing 麻豆原创 Size (2019-2030)
9.2 Latin America Covid-19 Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Covid-19 Testing 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Covid-19 Testing 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Testing 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Covid-19 Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Covid-19 Testing 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Covid-19 Testing 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Detail
11.1.2 Cellex Business Overview
11.1.3 Cellex Covid-19 Testing Introduction
11.1.4 Cellex Revenue in Covid-19 Testing Business (2019-2024)
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Covid-19 Testing Introduction
11.2.4 Abbott Revenue in Covid-19 Testing Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Covid-19 Testing Introduction
11.3.4 Roche Revenue in Covid-19 Testing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Detail
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics Covid-19 Testing Introduction
11.4.4 BioMedomics Revenue in Covid-19 Testing Business (2019-2024)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Covid-19 Testing Introduction
11.5.4 BD Revenue in Covid-19 Testing Business (2019-2024)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Detail
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein Covid-19 Testing Introduction
11.6.4 Henry Schein Revenue in Covid-19 Testing Business (2019-2024)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Detail
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech Covid-19 Testing Introduction
11.7.4 Safecare Bio-Tech Revenue in Covid-19 Testing Business (2019-2024)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Detail
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories Covid-19 Testing Introduction
11.8.4 Mayo Clinic Laboratories Revenue in Covid-19 Testing Business (2019-2024)
11.8.5 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Detail
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics Covid-19 Testing Introduction
11.9.4 Chembio Diagnostics Revenue in Covid-19 Testing Business (2019-2024)
11.9.5 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Detail
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory Covid-19 Testing Introduction
11.10.4 Mount Sinai Laboratory Revenue in Covid-19 Testing Business (2019-2024)
11.10.5 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics Covid-19 Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in Covid-19 Testing Business (2019-2024)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Detail
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech Covid-19 Testing Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in Covid-19 Testing Business (2019-2024)
11.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Detail
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology Covid-19 Testing Introduction
11.13.4 Innovita Biological Technology Revenue in Covid-19 Testing Business (2019-2024)
11.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Detail
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech Covid-19 Testing Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in Covid-19 Testing Business (2019-2024)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Detail
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific Covid-19 Testing Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in Covid-19 Testing Business (2019-2024)
11.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Detail
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) Covid-19 Testing Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in Covid-19 Testing Business (2019-2024)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
11.17.1 ADVAITE Company Detail
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE Covid-19 Testing Introduction
11.17.4 ADVAITE Revenue in Covid-19 Testing Business (2019-2024)
11.17.5 ADVAITE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.